Johnson's One Dose Easy Wormer for Small Dogs and Puppies, 100 mg Film Coated Tablets

Երկիր: Միացյալ Թագավորություն

Լեզու: անգլերեն

Աղբյուրը: VMD (Veterinary Medicines Directorate)

Ակտիվ բաղադրիչ:

Nitroscanate

Հասանելի է:

Elanco Europe Ltd

ATC կոդը:

QP52AX01

INN (Միջազգային անվանումը):

Nitroscanate

Դեղագործական ձեւ:

Film-coated tablet

Ռեկվիզորի տեսակը:

AVM-GSL - Authorised Veterinary Medicine – General Sales List

Թերապեւտիկ խումբ:

Dogs

Թերապեւտիկ տարածք:

Anthelmintic

Լիազորման կարգավիճակը:

Expired

Հաստատման ամսաթիվը:

1998-01-26

Ապրանքի հատկությունները

Revised: October 2020
AN: 00986/2020
Page 1 of 4
SUMMARY OF PRODUCT CHARACTERISTICS
1.
NAME OF THE VETERINARY MEDICINAL PRODUCT
Johnson’s One Dose Easy Wormer for Small Dogs and Puppies,
100 mg film coated tablets
2.
QUALITATIVE AND QUANTITATIVE COMPOSITION
Active ingredient
mg/tablet
Nitroscanate
100
For a full list of excipients see section 6.1.
3.
PHARMACEUTICAL FORM
Film coated tablet.
Yellowish-white to light beige round, film coated tablet, with imprint
1.
kx and imprint 2. CGV.
4.
CLINICAL PARTICULARS
4.1
TARGET SPECIES
Dogs.
4.2
INDICATIONS FOR USE, SPECIFYING THE TARGET SPECIES
Nitroscanate is a broad spectrum anthelmintic for use in dogs. It is
highly effective in a single dose against common canine nematodes
and cestodes in the UK: _Toxocara canis, Toxascaris leonina, _
_Ancylostoma caninum, Uncinaria stenocephala, Taenia ovis, Taenia _
_hydatigena, Taenia pisiformis _and _Dipylidium caninum._
At the recommended dosage, the product gives limited control of
_Echinococcus granulosus._
4.3
CONTRAINDICATIONS
None.
4.4
SPECIAL WARNINGS FOR EACH TARGET SPECIES
None.
Revised: October 2020
AN: 00986/2020
Page 2 of 4
4.5
SPECIAL PRECAUTIONS FOR USE
I)
SPECIAL PRECAUTIONS FOR USE IN ANIMALS
Do not repeat treatment if vomiting occurs shortly after dosing.
II)
SPECIAL PRECAUTIONS TO BE TAKEN BY THE PERSON ADMINISTERING
THE MEDICINAL PRODUCT TO ANIMALS
Tablets are film coated and should not be broken or divided.
4.6
ADVERSE REACTIONS (FREQUENCY AND SERIOUSNESS)
The tablets, when administered as recommended are unlikely to cause
vomiting. Do not repeat treatment if vomiting occurs shortly after
dosing.
4.7
USE DURING PREGNANCY, LACTATION OR LAY
Not contraindicated in pregnant animals. Nursing females should be
treated at the same time and as frequently as puppies up to 12 weeks
of age (i.e. 2, 4, 6, 8, 12 weeks).
4.8
INTERACTION WITH OTHER MEDICINAL PRODUCTS AND OTHER FORMS OF
INTERACTION
None known.
4.9
AMOUNT(S) TO BE ADMINISTERED AND ADMINISTRATION ROUTE
For the routine treatment of puppies and adult dogs up to